share_log

Amedisys Analyst Ratings

Amedisys Analyst Ratings

Amedisys 分析师评级
Benzinga ·  2023/07/31 15:42
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
07/31/2023 11.24% TD Cowen $84 → $101 Maintains Market Perform
07/27/2023 11.24% Credit Suisse → $101 Reiterates Neutral → Neutral
07/06/2023 11.24% Jefferies $98 → $101 Downgrades Buy → Hold
06/28/2023 — Benchmark Downgrades Buy → Hold
06/27/2023 — Benchmark Downgrades Buy → Hold
06/27/2023 11.24% Truist Securities $97 → $101 Maintains Hold
06/07/2023 6.84% Truist Securities → $97 Downgrades Buy → Hold
06/06/2023 10.14% Cantor Fitzgerald $91 → $100 Maintains Neutral
06/06/2023 26.66% Benchmark → $115 Reiterates Buy → Buy
06/06/2023 10.14% Credit Suisse $115 → $100 Downgrades Outperform → Neutral
05/08/2023 -7.48% TD Cowen $95 → $84 Maintains Market Perform
05/05/2023 -3.07% Barclays $93 → $88 Maintains Equal-Weight
05/04/2023 6.84% Truist Securities $115 → $97 Maintains Buy
05/04/2023 13.45% Stephens & Co. → $103 Reiterates → Equal-Weight
04/21/2023 -4.18% Cantor Fitzgerald → $87 Initiates Coverage On → Neutral
04/13/2023 26.66% Truist Securities $130 → $115 Maintains Buy
03/14/2023 26.66% Benchmark → $115 Reiterates → Buy
03/14/2023 13.45% Stephens & Co. → $103 Reiterates → Equal-Weight
03/13/2023 2.43% Barclays → $93 Initiates Coverage On → Equal-Weight
02/27/2023 26.66% Credit Suisse → $115 Reiterates → Outperform
02/21/2023 22.26% RBC Capital $114 → $111 Maintains Outperform
02/16/2023 4.64% Stephens & Co. → $95 Reiterates → Equal-Weight
02/16/2023 26.66% Benchmark $120 → $115 Maintains Buy
02/13/2023 32.17% Benchmark → $120 Reiterates → Buy
01/25/2023 32.17% Benchmark $135 → $120 Maintains Buy
01/23/2023 26.66% Credit Suisse $140 → $115 Maintains Outperform
01/19/2023 37.68% Oppenheimer $145 → $125 Maintains Outperform
01/05/2023 -6.38% SVB Leerink $96 → $85 Maintains Market Perform
11/11/2022 16.75% Stephens & Co. $122 → $106 Maintains Equal-Weight
11/01/2022 5.74% SVB Leerink $116 → $96 Maintains Market Perform
11/01/2022 34.37% Stephens & Co. $105 → $122 Maintains Equal-Weight
10/31/2022 53.1% RBC Capital $165 → $139 Maintains Outperform
10/28/2022 38.78% Barclays $154 → $126 Maintains Overweight
10/28/2022 15.65% Stephens & Co. $120 → $105 Maintains Equal-Weight
10/28/2022 43.19% Truist Securities $140 → $130 Maintains Buy
10/28/2022 59.71% Oppenheimer $175 → $145 Maintains Outperform
10/27/2022 — Raymond James Downgrades Outperform → Market Perform
10/24/2022 81.74% Deutsche Bank $175 → $165 Maintains Buy
10/05/2022 54.2% Truist Securities $150 → $140 Maintains Buy
10/03/2022 48.69% Benchmark $165 → $135 Maintains Buy
08/02/2022 4.64% UBS $145 → $95 Downgrades Neutral → Sell
08/01/2022 54.2% Raymond James $180 → $140 Maintains Outperform
07/29/2022 69.62% Barclays $181 → $154 Maintains Overweight
07/28/2022 81.74% Benchmark $175 → $165 Maintains Buy
07/14/2022 65.21% Truist Securities $175 → $150 Maintains Buy
06/29/2022 40.98% Stifel → $128 Initiates Coverage On → Hold
06/21/2022 12.35% B of A Securities $145 → $102 Downgrades Neutral → Underperform
06/21/2022 92.75% Deutsche Bank $210 → $175 Maintains Buy
06/21/2022 92.75% Truist Securities $200 → $175 Maintains Buy
06/21/2022 37.68% Stephens & Co. $155 → $125 Maintains Equal-Weight
06/21/2022 17.85% SVB Leerink $117 → $107 Maintains Market Perform
05/27/2022 28.87% SVB Leerink $131 → $117 Maintains Market Perform
04/29/2022 100.46% Credit Suisse $181 → $182 Maintains Outperform
04/29/2022 98.26% Raymond James $200 → $180 Maintains Outperform
04/29/2022 44.29% SVB Leerink $162 → $131 Maintains Market Perform
03/01/2022 85.04% UBS $152 → $168 Upgrades Sell → Neutral
02/25/2022 114.78% Credit Suisse $200 → $195 Maintains Outperform
02/25/2022 120.29% Oppenheimer $225 → $200 Maintains Outperform
02/25/2022 109.27% BMO Capital → $190 Upgrades Market Perform → Outperform
02/24/2022 92.75% Benchmark $200 → $175 Maintains Buy
02/18/2022 61.91% SVB Leerink $145 → $147 Maintains Market Perform
12/21/2021 134.6% Barclays $236 → $213 Maintains Overweight
11/08/2021 147.82% Raymond James $250 → $225 Maintains Outperform
11/04/2021 125.79% Credit Suisse $192 → $205 Maintains Outperform
11/04/2021 103.76% Stephens & Co. $178 → $185 Maintains Equal-Weight
11/04/2021 143.42% RBC Capital $244 → $221 Maintains Outperform
11/04/2021 99.36% SVB Leerink $170 → $181 Maintains Market Perform
11/03/2021 147.82% Oppenheimer $265 → $225 Maintains Outperform
10/13/2021 109.27% Truist Securities $255 → $190 Maintains Buy
09/27/2021 87.24% SVB Leerink → $170 Initiates Coverage On → Market Perform
09/24/2021 65.21% UBS → $150 Initiates Coverage On → Sell
09/10/2021 114.78% Cowen & Co. → $195 Initiates Coverage On → Market Perform
08/11/2021 175.36% Credit Suisse $330 → $250 Maintains Outperform
08/10/2021 158.84% Benchmark $325 → $235 Maintains Buy
08/10/2021 175.36% Raymond James $325 → $250 Maintains Outperform
08/06/2021 191.88% Oppenheimer $325 → $265 Maintains Outperform
08/06/2021 161.04% Stephens & Co. $310 → $237 Maintains Equal-Weight
08/05/2021 142.31% B of A Securities → $220 Downgrades Buy → Neutral
02/23/2021 257.96% Benchmark $275 → $325 Maintains Buy
02/08/2021 274.49% Deutsche Bank $275 → $340 Maintains Buy
10/30/2020 208.4% Credit Suisse $246 → $280 Maintains Outperform
09/21/2020 186.37% Oppenheimer $250 → $260 Maintains Outperform
09/02/2020 197.39% BMO Capital $250 → $270 Maintains Market Perform
07/30/2020 197.39% SunTrust Robinson Humphrey $260 → $270 Maintains Buy
07/30/2020 180.86% Raymond James $210 → $255 Maintains Outperform
07/30/2020 186.37% Deutsche Bank $220 → $260 Maintains Buy
07/30/2020 175.36% Benchmark $210 → $250 Maintains Buy
07/30/2020 186.37% RBC Capital $218 → $260 Maintains Outperform
07/29/2020 175.36% Jefferies $225 → $250 Maintains Buy
07/10/2020 186.37% SunTrust Robinson Humphrey $240 → $260 Maintains Buy
06/18/2020 131.3% Benchmark → $210 Upgrades Hold → Buy
05/21/2020 164.34% SunTrust Robinson Humphrey $225 → $240 Maintains Buy
05/11/2020 109.27% UBS $208 → $190 Maintains Neutral
05/11/2020 131.3% Raymond James $225 → $210 Maintains Outperform
03/09/2020 125.79% Benchmark → $205 Upgrades Hold → Buy
02/21/2020 129.1% UBS $154 → $208 Maintains Neutral
02/21/2020 120.29% Stephens & Co. $180 → $200 Maintains Equal-Weight
02/20/2020 147.82% SunTrust Robinson Humphrey $185 → $225 Maintains Buy
02/20/2020 147.82% Raymond James $200 → $225 Maintains Outperform
01/17/2020 126.89% Credit Suisse → $206 Initiates Coverage On → Outperform
01/03/2020 120.29% Raymond James $144 → $200 Maintains Outperform
12/18/2019 103.76% SunTrust Robinson Humphrey $175 → $185 Maintains Buy
12/06/2019 87.24% BMO Capital → $170 Initiates Coverage On → Market Perform
11/26/2019 96.05% B of A Securities $170 → $178 Maintains Buy
11/20/2019 87.24% B of A Securities $163 → $170 Reiterates → Buy
11/07/2019 69.62% UBS $144 → $154 Maintains Neutral
11/01/2019 — Baird Upgrades Neutral → Outperform
10/22/2019 59.71% Stephens & Co. → $145 Reinstates → Equal-Weight
09/17/2019 70.72% Deutsche Bank → $155 Initiates Coverage On → Buy
08/05/2019 37.68% Barclays $120 → $125 Maintains Equal-Weight
07/15/2019 58.61% Raymond James $140 → $144 Maintains Outperform
05/02/2019 54.2% Raymond James → $140 Upgrades Market Perform → Outperform
03/21/2019 32.17% Barclays $115 → $120 Maintains Equal-Weight
02/05/2019 — Benchmark Downgrades Buy → Hold
12/14/2018 43.19% Barclays → $130 Initiates Coverage On → Equal-Weight
11/16/2018 38.78% UBS → $126 Initiates Coverage On → Neutral
10/30/2018 — Benchmark Upgrades Hold → Buy
10/26/2018 14.55% Craig-Hallum $116 → $104 Downgrades Buy → Hold
10/11/2018 32.17% Baird $105 → $120 Maintains Neutral
10/11/2018 37.68% Cantor Fitzgerald $117 → $125 Maintains Neutral
09/18/2018 53.1% B of A Securities $116 → $139 Maintains Buy
09/13/2018 28.87% Cantor Fitzgerald → $117 Initiates Coverage On → Neutral
日期 上行/下行 分析公司 目标价格变化 评级变化 上一次/当前评级
07/31/2023 11.24% TD Cowen $84→$101 维护 市场表现
07/27/2023 11.24% 瑞士信贷 →$101 重申 中性→中性
07/06/2023 11.24% 杰富瑞 $98→$101 评级下调 购买→Hold
2023年6月28日 - 基准 评级下调 购买→Hold
2023年6月27日 - 基准 评级下调 购买→Hold
2023年6月27日 11.24% Truist证券 $97→$101 维护 保持
06/07/2023 6.84% Truist证券 →$97 评级下调 购买→Hold
06/06/2023 10.14% 康托·菲茨杰拉德 $91→$100 维护 中性
06/06/2023 26.66% 基准 →$115 重申 购买→购买
06/06/2023 10.14% 瑞士信贷 $115→$100 评级下调 跑赢→中性
05/08/2023 -7.48% TD Cowen $95→$84 维护 市场表现
05/05/2023 -3.07% 巴克莱 $93→$88 维护 等重
05/04/2023 6.84% Truist证券 $115→$97 维护 买
05/04/2023 13.45% 斯蒂芬斯公司 →$103 重申 →等重
04/21/2023 -4.18% 康托·菲茨杰拉德 →$87 开始承保 →中性
04/13/2023 26.66% Truist证券 $130→$115 维护 买
03/14/2023 26.66% 基准 →$115 重申 →购买
03/14/2023 13.45% 斯蒂芬斯公司 →$103 重申 →等重
03/13/2023 2.43% 巴克莱 →$93 开始承保 →等重
02/27/2023 26.66% 瑞士信贷 →$115 重申 →跑赢大盘
02/21/2023 22.26% 加拿大皇家银行资本 $114→$111 维护 跑赢大盘
02/16/2023 4.64% 斯蒂芬斯公司 →$95 重申 →等重
02/16/2023 26.66% 基准 $120→$115 维护 买
02/13/2023 32.17% 基准 →$120 重申 →购买
2023年1月25日 32.17% 基准 $135→$120 维护 买
2023年1月23日 26.66% 瑞士信贷 $140→$115 维护 跑赢大盘
2023年1月19日 37.68% 奥本海默 $145→$125 维护 跑赢大盘
01/05/2023 -6.38% SVB Leerink $96→$85 维护 市场表现
2022年11月11日 16.75% 斯蒂芬斯公司 $122→$106 维护 等重
11/01/2022 5.74% SVB Leerink $116→$96 维护 市场表现
11/01/2022 34.37% 斯蒂芬斯公司 $105→$122 维护 等重
2022年10月31日 53.1% 加拿大皇家银行资本 $165→$139 维护 跑赢大盘
10/28/2022 38.78% 巴克莱 $154→$126 维护 超重
10/28/2022 15.65% 斯蒂芬斯公司 $120→$105 维护 等重
10/28/2022 43.19% Truist证券 $140→$130 维护 买
10/28/2022 59.71% 奥本海默 $175→$145 维护 跑赢大盘
10/27/2022 - 雷蒙德·詹姆斯 评级下调 跑赢→市场表现
10/24/2022 81.74% 德意志银行 $175→$165 维护 买
10/05/2022 54.2% Truist证券 $150→$140 维护 买
10/03/2022 48.69% 基准 $165→$135 维护 买
08/02/2022 4.64% 瑞银集团 $145→$95 评级下调 中性→销售
08/01/2022 54.2% 雷蒙德·詹姆斯 $180→$140 维护 跑赢大盘
07/29/2022 69.62% 巴克莱 $181→$154 维护 超重
07/28/2022 81.74% 基准 $175→$165 维护 买
07/14/2022 65.21% Truist证券 $175→$150 维护 买
2022/06/29 40.98% Stifel →$128 开始承保 →保留
2022年06月21日 12.35% B of A证券 $145→$102 评级下调 中性→表现不佳
2022年06月21日 92.75% 德意志银行 $210→$175 维护 买
2022年06月21日 92.75% Truist证券 $200→$175 维护 买
2022年06月21日 37.68% 斯蒂芬斯公司 $155→$125 维护 等重
2022年06月21日 17.85% SVB Leerink $117→$107 维护 市场表现
2022年05月27日 28.87% SVB Leerink $131→$117 维护 市场表现
04/29/2022 100.46% 瑞士信贷 $181→$182 维护 跑赢大盘
04/29/2022 98.26% 雷蒙德·詹姆斯 $200→$180 维护 跑赢大盘
04/29/2022 44.29% SVB Leerink $162→$131 维护 市场表现
03/01/2022 85.04% 瑞银集团 $152→$168 升级 卖出→中性
02/25/2022 114.78% 瑞士信贷 $200→$195 维护 跑赢大盘
02/25/2022 120.29% 奥本海默 $225→$200 维护 跑赢大盘
02/25/2022 109.27% 蒙特利尔银行资本 →$190 升级 市场表现优于→
02/24/2022 92.75% 基准 $200→$175 维护 买
02/18/2022 61.91% SVB Leerink $145→$147 维护 市场表现
2021/12/21 134.6% 巴克莱 $236→$213 维护 超重
11/08/2021 147.82% 雷蒙德·詹姆斯 $250→$225 维护 跑赢大盘
11/04/2021 125.79% 瑞士信贷 $192→$205 维护 跑赢大盘
11/04/2021 103.76% 斯蒂芬斯公司 $178→$185 维护 等重
11/04/2021 143.42% 加拿大皇家银行资本 $244→$221 维护 跑赢大盘
11/04/2021 99.36% SVB Leerink $170→$181 维护 市场表现
11/03/2021 147.82% 奥本海默 $265→$225 维护 跑赢大盘
10/13/2021 109.27% Truist证券 $255→$190 维护 买
09/27/2021 87.24% SVB Leerink →$170 开始承保 →市场表现
09/24/2021 65.21% 瑞银集团 →$150 开始承保 →销售
09/10/2021 114.78% 考恩公司 →$195 开始承保 →市场表现
2021/08/11 175.36% 瑞士信贷 $330→$250 维护 跑赢大盘
2021/08/10 158.84% 基准 $325→$235 维护 买
2021/08/10 175.36% 雷蒙德·詹姆斯 $325→$250 维护 跑赢大盘
08/06/2021 191.88% 奥本海默 $325→$265 维护 跑赢大盘
08/06/2021 161.04% 斯蒂芬斯公司 $310→$237 维护 等重
08/05/2021 142.31% B of A证券 →$220 评级下调 购买→中性
02/23/2021 257.96% 基准 $275→$325 维护 买
02/08/2021 274.49% 德意志银行 $275→$340 维护 买
10/30/2020 208.4% 瑞士信贷 $246→$280 维护 跑赢大盘
2020/09/21 186.37% 奥本海默 $250→$260 维护 跑赢大盘
09/02/2020 197.39% 蒙特利尔银行资本 $250→$270 维护 市场表现
07/30/2020 197.39% SunTrust Robinson Humphrey $260→$270 维护 买
07/30/2020 180.86% 雷蒙德·詹姆斯 $210→$255 维护 跑赢大盘
07/30/2020 186.37% 德意志银行 $220→$260 维护 买
07/30/2020 175.36% 基准 $210→$250 维护 买
07/30/2020 186.37% 加拿大皇家银行资本 $218→$260 维护 跑赢大盘
07/29/2020 175.36% 杰富瑞 $225→$250 维护 买
07/10/2020 186.37% SunTrust Robinson Humphrey $240→$260 维护 买
06/18/2020 131.3% 基准 →$210 升级 持有→购买
2020/05/21 164.34% SunTrust Robinson Humphrey $225→$240 维护 买
05/11/2020 109.27% 瑞银集团 $208→$190 维护 中性
05/11/2020 131.3% 雷蒙德·詹姆斯 $225→$210 维护 跑赢大盘
03/09/2020 125.79% 基准 →$205 升级 持有→购买
02/21/2020 129.1% 瑞银集团 $154→$208 维护 中性
02/21/2020 120.29% 斯蒂芬斯公司 $180→$200 维护 等重
02/20/2020 147.82% SunTrust Robinson Humphrey $185→$225 维护 买
02/20/2020 147.82% 雷蒙德·詹姆斯 $200→$225 维护 跑赢大盘
2020/01/17 126.89% 瑞士信贷 →$206 开始承保 →跑赢大盘
1/03/2020 120.29% 雷蒙德·詹姆斯 $144→$200 维护 跑赢大盘
2019年12月18日 103.76% SunTrust Robinson Humphrey $175→$185 维护 买
2019年6月12日 87.24% 蒙特利尔银行资本 →$170 开始承保 →市场表现
2019年11月26日 96.05% B of A证券 $170→$178 维护 买
2019年11月20日 87.24% B of A证券 $163→$170 重申 →购买
2019/07/11 69.62% 瑞银集团 $144→$154 维护 中性
2019/11/01 - 贝尔德 升级 中性→表现优异
2019年10月22日 59.71% 斯蒂芬斯公司 →$145 恢复 →等重
2019/09/17 70.72% 德意志银行 →$155 开始承保 →购买
2019年08月05日 37.68% 巴克莱 $120→$125 维护 等重
2019年07月15日 58.61% 雷蒙德·詹姆斯 $140→$144 维护 跑赢大盘
2019年05月02日 54.2% 雷蒙德·詹姆斯 →$140 升级 市场表现优于→
2019年03月21日 32.17% 巴克莱 $115→$120 维护 等重
2019年05月02日 - 基准 评级下调 购买→Hold
2018年12月14日 43.19% 巴克莱 →$130 开始承保 →等重
2018年11月16日 38.78% 瑞银集团 →$126 开始承保 →中性
2018年10月30日 - 基准 升级 持有→购买
2018年10月26日 14.55% 克雷格-哈勒姆 $116→$104 评级下调 购买→Hold
2018年10月11日 32.17% 贝尔德 $105→$120 维护 中性
2018年10月11日 37.68% 康托·菲茨杰拉德 $117→$125 维护 中性
2018年09月18日 53.1% B of A证券 $116→$139 维护 买
2018年09月13日 28.87% 康托·菲茨杰拉德 →$117 开始承保 →中性

What is the target price for Amedisys (AMED)?

Amedisys(Amed)的目标价是多少？

The latest price target for Amedisys (NASDAQ: AMED) was reported by TD Cowen on July 31, 2023. The analyst firm set a price target for $101.00 expecting AMED to rise to within 12 months (a possible 11.24% upside). 42 analyst firms have reported ratings in the last year.

TD Cowen于2023年7月31日报道了Amedisys(纳斯达克代码：AMED)的最新目标价。这家分析公司将目标价定为101.00美元，预计Amed将在12个月内上涨至11.24%(可能上涨11.24%)。去年有42家分析公司公布了评级。

What is the most recent analyst rating for Amedisys (AMED)?

Amedisys(Amed)的最新分析师评级是多少？

The latest analyst rating for Amedisys (NASDAQ: AMED) was provided by TD Cowen, and Amedisys maintained their market perform rating.

TD Cowen提供了对Amedisys(纳斯达克代码：AMED)的最新分析师评级，Amedisys维持其市场表现评级。

When is the next analyst rating going to be posted or updated for Amedisys (AMED)?

Amedisys(Amed)的下一次分析师评级将于何时发布或更新？

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amedisys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amedisys was filed on July 31, 2023 so you should expect the next rating to be made available sometime around July 31, 2024.

分析师在进行了广泛的研究后得出了股票评级，其中包括查阅公共财务报表，与Amedisys的高管和客户交谈，以及听取收益电话会议。大多数分析师每三个月就会这样做一次，所以你每年应该会得到每家公司每家公司的4个评级。Amedisys的上一次评级是在2023年7月31日提交的，所以你应该预计下一次评级将在2024年7月31日左右的某个时候公布。

Is the Analyst Rating Amedisys (AMED) correct?

分析师对Amedisys(Amed)的评级正确吗？

While ratings are subjective and will change, the latest Amedisys (AMED) rating was a maintained with a price target of $84.00 to $101.00. The current price Amedisys (AMED) is trading at is $90.79, which is within the analyst's predicted range.

虽然评级是主观的，并将发生变化，但最新的Amedisys(AMED)评级维持不变，目标价在84美元至101.00美元之间。Amedisys(Amed)目前的交易价格为90.79美元，在分析师的预测区间内。

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发